EMB-01 in Combination With Chemotherapy for Unresectable or Metastatic Colorectal Cancer
Clinical trial NCT07649655 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07649655
- Sponsor
- Shanghai EpimAb Biotherapeutics Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2028-03-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.